Home › Trial NCT07381543
Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
- Trial IDNCT07381543
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorPeking University Cancer Hospital & Institute
- Enrollment76
- Start date2026-03
- ConditionsLocalized Small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.